A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes
Condition: Genital Herpes Interventions: Biological: mRNA-1608; Biological: BEXSERO Sponsor: ModernaTX, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Knowledge of Young Adults About Genital Herpes
Condition: Genital Herpes Intervention: Other: data collection Sponsor: Université de Reims Champagne-Ardenne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2023 Category: Research Source Type: clinical trials